膀胱肿瘤与尿液分子标志物
摘要
本文主要综述一些尿液分子标记物:Survivin、CK、FDP、NMP、端粒酶、BTA、LewisX、微卫星不稳定性HA/HAase、bFGF等在膀胱肿瘤的筛查、早期诊断、术后随访应用中的研究进展,以期找到更为敏感、特异、实用的尿液分子标记物。
出处
《临床外科杂志》
2005年第8期521-523,共3页
Journal of Clinical Surgery
参考文献19
-
1Tamm I,Wang Y,Sausvile E,et al.IAP2 family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95),Bax,caspases,and anticancer drugs[J].Cancer Res,1998,58 (23):5315-5320.
-
2Smith SD,Wheeler MA,Plescia J,et al.Urine detection of survivin and diagnosis of bladder cancer[J].JAMA,2001,285(3):324-328.
-
3汪良,曾甫清,廖贵益,陈方敏.检测膀胱癌患者尿液脱落细胞中Survivin的表达及意义[J].临床泌尿外科杂志,2004,19(8):489-490. 被引量:4
-
4Christoph F,Muller M,Schostak M,et al.Quatitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse trancriptase-polymerase chain reaction[J].Urology,2004,64(1):157-161.
-
5Siracusano S,Niccolini B,Knez R,et al.The simultaneous use of telomerase,cytokeratin 20 and CD4 for bladder cancer detection in urine[J].Eur Urol,2005,47(3):327-333.
-
6Topsakal M,Karadeniz T,Anac M,et al.Assesment of fibrin-fibrinogen degradation products(Accu-Dx) test in bladder cancer patients[J].Eur Urol,2001,39(3):287-291.
-
7Siemens DR,Morales A,Johnston B,et al.A comparative analysis of rapid urine tests for the diagnosis of upper urinary tract malignancy[J].Can J Urol,2003,10(1):1754-1758.
-
8Kageyama S,Isono T,Iwaki H,et al.Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine[J].Clin Chem,2004,50(5):857-866.
-
9Iwaki H,Kageyama S,Isono T,et al.Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin,gamma-synuclein,and catechol-o-methyltransferase) identified by proteomic analysis[J].Cancer Sci,2004,95(12):955-961.
-
10Grossman HB,Messing E,Soloway M,et al.Detection of bladder cancer using a point-of -care protemic assay[J].JAMA,2005,16(7):810-816.
二级参考文献13
-
1Adida C, Crotty P L, McGrath J, et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation.Am J Pathol, 1998, 152: 43-49.
-
2Swana H S, Grossman D, Anthony J N, et al. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med, 1999, 341:452-453.
-
3Lehner R, Lucia M S, Jarboe E A, et al. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Appl Immunohistochem Mol Morphol. 2002,10: 134- 138.
-
4Smith SD, Wheeler M A, Plescia J, etal. Urine detection of survivin and diagnosis of bladder cancer. JAMA,2001, 285: 324-328.
-
5Sharp J D, Hausladen D A, Maher M G, et al. Bladder cancer detection with urinary survivin, an inhibitor of apoptosis. Front Biosci, 2002, 7: 36-41.
-
6Yagihashi A, Asanuma K, Nakamura M, et al. Detection of anti-survivin antibody in gastrointestinal cancer patients. Clin Chem, 2001, 47: 1729-1731.
-
7Campbell SC. Advances in angiogenesis research: relevance to urological oncology. J Urol, 1997, 158:1663-1674.
-
8Hartley-Asp B, Vukanovic J, Joseph IB, et al. Anti-angiogenic treatment with linomide as adjuvant to surgical castration in experimental prostate cancer. J Urol, 1997, 158:902-907.
-
9Obermair A, Speiser P, Reisenberger K, et al. Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patients. Cancer Lett, 1998, 130: 69-76.
-
10Dow JK, deVere White RW. Fibroblast growth factor 2: its structure and property, paracrine function, tumor agiogenesis, and prostate-related mitogenic and oncogenic functions. Urology,2000, 55: 800-806.
共引文献3
-
1何军,赵晓昆,沃奇军.ELISA法定量测定尿液Survivin蛋白的价值[J].海南医学,2006,17(12):117-118.
-
2邱东飚.凋亡抑制因子Survivin mRNA在肝癌组织中的表达及其意义[J].山西中医学院学报,2009,10(5):57-58.
-
3夏艳,刘雅莉,杨克虎,陈卫.RT-PCR技术检测尿液中survivin mRNA对膀胱癌诊断价值的系统评价[J].癌症,2010,29(4):487-494. 被引量:5
-
1杨庚,李昱.尿Cox-2蛋白、CK19和HAase联合检测在膀胱癌早期诊断中的应用[J].现代预防医学,2013,40(19):3664-3667. 被引量:2
-
2蔡建良,杨为民.透明质酸、透明质酸酶与膀胱肿瘤[J].现代泌尿外科杂志,2003,8(1):60-62.
-
3王继贵.临床实验室检查可用的膀胱癌尿标记物[J].国外医学(临床生物化学与检验学分册),2002,23(2):107-108. 被引量:2
-
4张文夏,桂律,李如昌.血型抗原Lewis A和Lewis X在膀胱移行细胞癌中的表达及其诊断价值[J].山西医科大学学报,2007,38(8):708-710.
-
5李娟,罗绍凯,熊文杰,黎军和.多发性骨髓瘤耐药细胞株核基质蛋白的变化[J].中华血液学杂志,2003,24(4):205-206. 被引量:1
-
6汪毅,任国胜,石远,王小毅,冉亮.透明质酸酶及基质金属蛋白酶-9在人乳腺癌侵袭与转移中的意义[J].中国微创外科杂志,2006,6(9):675-677.
-
7尚培中,张金江,刘景章,朱习琴,苗建军.基质金属蛋白酶-9和唾液酸化Lewis X在乳腺癌组织中的表达及其意义[J].中国医师杂志,2008,10(3):408-409. 被引量:1
-
8黄俊琪,张昌卿,区深明,刘乐和.抗肝癌NMP单克隆抗体的制备及初步鉴定[J].免疫学杂志,1999,15(1):49-53. 被引量:1
-
9金美花,德伟林,魏秀鸿.联合检测尿HAase和NMP-22活性水平在膀胱癌诊断和手术后复发的研究[J].中国实验诊断学,2010,14(8):1198-1199. 被引量:7
-
10沈周俊,金晓东,蔡松良.NMP 22与流式细胞术在膀胱癌诊断中的价值[J].中华泌尿外科杂志,2001,22(11):662-665. 被引量:5